SE9800550D0 - A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof - Google Patents
A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereofInfo
- Publication number
- SE9800550D0 SE9800550D0 SE9800550A SE9800550A SE9800550D0 SE 9800550 D0 SE9800550 D0 SE 9800550D0 SE 9800550 A SE9800550 A SE 9800550A SE 9800550 A SE9800550 A SE 9800550A SE 9800550 D0 SE9800550 D0 SE 9800550D0
- Authority
- SE
- Sweden
- Prior art keywords
- angiotensin
- type
- receptor agonist
- pharmaceutical preparation
- dyspepsia
- Prior art date
Links
- 102000025309 Type 2 Angiotensin Receptor Human genes 0.000 title abstract 4
- 108010062475 Type 2 Angiotensin Receptor Proteins 0.000 title abstract 4
- 239000000018 receptor agonist Substances 0.000 title abstract 4
- 229940044601 receptor agonist Drugs 0.000 title abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 208000034486 Multi-organ failure Diseases 0.000 abstract 3
- 208000010718 Multiple Organ Failure Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 208000035475 disorder Diseases 0.000 abstract 3
- 201000006549 dyspepsia Diseases 0.000 abstract 3
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 3
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| EEP200000481A EE200000481A (et) | 1998-02-24 | 1999-02-24 | Angiotensiin II 2. tüüpi retseptori agonisti sisaldav farmatseutiline preparaat ja selle kasutamine |
| BR9908188-1A BR9908188A (pt) | 1998-02-24 | 1999-02-24 | Preparação farmacêutica, uso de um agonista de receptor de tipo 2 de angiotensina ii ou de um seu sal fisiologicamente aceitável, e, processo para tratamento e/ou prevenção de uma afecção selecionada do grupo consistindo de distúrbios do trato alimentar, tais como dispepsia, sìndrome de intestino irritável e/ou insuficiência múltipla de órgãos em um paciente |
| CN99803230A CN1291104A (zh) | 1998-02-24 | 1999-02-24 | 含有血管紧张素ⅱ2型受体激动剂的药物制剂及其应用 |
| EP99908017A EP1066048A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| IL13799099A IL137990A0 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| AU27537/99A AU755949B2 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| HU0101411A HUP0101411A3 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| MXPA00008172A MXPA00008172A (es) | 1998-02-24 | 1999-02-24 | Preparacion farmacologica que comprende un agonista del receptor tipo 2 de la angiotensina ii y utilizacion de la misma. |
| CA002319123A CA2319123A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| NZ506188A NZ506188A (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| KR1020007009295A KR20010041211A (ko) | 1998-02-24 | 1999-02-24 | 안지오텐신 ιι 타입 2 수용체 효능제를 포함하는 제약제제 및 그의 용도 |
| IDW20001909A ID26639A (id) | 1998-02-24 | 1999-02-24 | Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya |
| JP2000533135A JP2002504516A (ja) | 1998-02-24 | 1999-02-24 | アンギオテンシンｉｉ型２リセプタ作用薬を含む医薬製剤およびその使用 |
| SK1152-2000A SK11522000A3 (sk) | 1998-02-24 | 1999-02-24 | Farmaceutický prípravok obsahujúci agonistu receptora angiotenzínu ii typu 2 a jeho použitie |
| PCT/SE1999/000262 WO1999043339A1 (en) | 1998-02-24 | 1999-02-24 | A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| IS5594A IS5594A (is) | 1998-02-24 | 2000-08-21 | Lyfjablanda sem inniheldur gerandefni angíótensínII viðtaka af gerð 2 og notkun hennar |
| NO20004215A NO20004215L (no) | 1998-02-24 | 2000-08-23 | Et farmasøytisk preparat som omfatter en angiotensin II type 2-reseptoragonist, og anvendelse derav |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9800550D0 true SE9800550D0 (sv) | 1998-02-24 |
Family
ID=20410283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9800550A SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1066048A1 (sv) |
| JP (1) | JP2002504516A (sv) |
| KR (1) | KR20010041211A (sv) |
| CN (1) | CN1291104A (sv) |
| AU (1) | AU755949B2 (sv) |
| BR (1) | BR9908188A (sv) |
| CA (1) | CA2319123A1 (sv) |
| EE (1) | EE200000481A (sv) |
| HU (1) | HUP0101411A3 (sv) |
| ID (1) | ID26639A (sv) |
| IL (1) | IL137990A0 (sv) |
| IS (1) | IS5594A (sv) |
| MX (1) | MXPA00008172A (sv) |
| NO (1) | NO20004215L (sv) |
| NZ (1) | NZ506188A (sv) |
| SE (1) | SE9800550D0 (sv) |
| SK (1) | SK11522000A3 (sv) |
| WO (1) | WO1999043339A1 (sv) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60017793T2 (de) * | 1999-12-16 | 2006-01-05 | University Of Southern California, Los Angeles | Verfahren zur vorbeugung und behandlung von beschädigungen des schleimhautgewebes |
| US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
| WO2002096883A1 (en) | 2001-05-31 | 2002-12-05 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| JP5202301B2 (ja) | 2005-04-12 | 2013-06-05 | ヴィコール・ファルマ・アーベー | 新規な三環系アンジオテンシンｉｉアゴニスト |
| IN2014DN02217A (sv) | 2005-04-12 | 2015-07-10 | Vicore Pharma Ab | |
| DE602006018122D1 (de) | 2005-04-12 | 2010-12-23 | Vicore Pharma Ab | Neue tricyclische angiotensin-ii-agonisten |
| AU2006326404B2 (en) * | 2005-12-14 | 2011-11-03 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| US20150119329A1 (en) * | 2012-04-16 | 2015-04-30 | New York University | Modulation of angiotensin ii receptors for the prevention and treatment of malaria cerebral |
| WO2016139475A1 (en) | 2015-03-02 | 2016-09-09 | Vicore Pharma Ab | Angiotensin ii receptor agonist for treating pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| US20220257698A1 (en) | 2019-08-02 | 2022-08-18 | Lanthiopep B.V. | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
| GB201913603D0 (en) | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| CA3175559A1 (en) | 2020-03-19 | 2021-09-23 | Vicore Pharma Ab | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii |
| GB202004094D0 (en) | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
| GB202006081D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006074D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202006079D0 (en) | 2020-04-24 | 2020-06-10 | Vicore Pharma Ab | New composition |
| GB202013721D0 (en) | 2020-09-01 | 2020-10-14 | Vicore Pharma Ab | New compounds |
| EP4313953A1 (en) | 2021-03-23 | 2024-02-07 | Vicore Pharma AB | Selective angiotensin ii receptor ligands |
| GB202104038D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| GB202104033D0 (en) | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| JP2024523576A (ja) | 2021-07-09 | 2024-06-28 | ヴィコール ファルマ アーベー | 新規の選択的アンジオテンシンｉｉ化合物 |
| GB202115303D0 (en) | 2021-10-25 | 2021-12-08 | Vicore Pharma Ab | New formulation |
| EP4475843A1 (en) | 2022-02-10 | 2024-12-18 | Vicore Pharma AB | Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis |
| GB202201723D0 (en) | 2022-02-10 | 2022-03-30 | Vicore Pharma Ab | New use |
| TW202404959A (zh) | 2022-04-06 | 2024-02-01 | 大陸商武漢人福創新藥物研發中心有限公司 | At2r促效劑 |
| GB2640807A (en) | 2022-12-22 | 2025-11-05 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| CN120569378A (zh) | 2023-01-09 | 2025-08-29 | 维科尔药物公司 | 选择性血管紧张素ii化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444067A (en) * | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| AU3708295A (en) * | 1994-11-04 | 1996-05-31 | Stefan L. Marklund | Use of receptor agonists to stimulate superoxide dismutase activity |
| SE9501881D0 (sv) * | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
| US5834432A (en) * | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
| SE9502219D0 (sv) * | 1995-06-19 | 1995-06-19 | Astra Ab | Novel medical use |
-
1998
- 1998-02-24 SE SE9800550A patent/SE9800550D0/sv unknown
-
1999
- 1999-02-24 ID IDW20001909A patent/ID26639A/id unknown
- 1999-02-24 EE EEP200000481A patent/EE200000481A/xx unknown
- 1999-02-24 CN CN99803230A patent/CN1291104A/zh active Pending
- 1999-02-24 KR KR1020007009295A patent/KR20010041211A/ko not_active Withdrawn
- 1999-02-24 SK SK1152-2000A patent/SK11522000A3/sk unknown
- 1999-02-24 MX MXPA00008172A patent/MXPA00008172A/es unknown
- 1999-02-24 IL IL13799099A patent/IL137990A0/xx unknown
- 1999-02-24 WO PCT/SE1999/000262 patent/WO1999043339A1/en not_active Ceased
- 1999-02-24 CA CA002319123A patent/CA2319123A1/en not_active Abandoned
- 1999-02-24 EP EP99908017A patent/EP1066048A1/en not_active Withdrawn
- 1999-02-24 HU HU0101411A patent/HUP0101411A3/hu unknown
- 1999-02-24 JP JP2000533135A patent/JP2002504516A/ja active Pending
- 1999-02-24 NZ NZ506188A patent/NZ506188A/xx unknown
- 1999-02-24 AU AU27537/99A patent/AU755949B2/en not_active Ceased
- 1999-02-24 BR BR9908188-1A patent/BR9908188A/pt not_active IP Right Cessation
-
2000
- 2000-08-21 IS IS5594A patent/IS5594A/is unknown
- 2000-08-23 NO NO20004215A patent/NO20004215L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004215L (no) | 2000-09-18 |
| CN1291104A (zh) | 2001-04-11 |
| ID26639A (id) | 2001-01-25 |
| BR9908188A (pt) | 2000-10-24 |
| NO20004215D0 (no) | 2000-08-23 |
| NZ506188A (en) | 2003-04-29 |
| KR20010041211A (ko) | 2001-05-15 |
| CA2319123A1 (en) | 1999-09-02 |
| MXPA00008172A (es) | 2002-06-21 |
| IS5594A (is) | 2000-08-21 |
| AU755949B2 (en) | 2003-01-02 |
| EE200000481A (et) | 2002-02-15 |
| EP1066048A1 (en) | 2001-01-10 |
| SK11522000A3 (sk) | 2001-04-09 |
| HUP0101411A2 (hu) | 2002-03-28 |
| AU2753799A (en) | 1999-09-15 |
| IL137990A0 (en) | 2001-10-31 |
| WO1999043339A1 (en) | 1999-09-02 |
| HUP0101411A3 (en) | 2002-11-28 |
| JP2002504516A (ja) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9800550D0 (sv) | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof | |
| RU2220723C2 (ru) | Средство и способ лечения или профилактики артериосклероза | |
| Rabinowitz et al. | The effect of clozapine on saliva flow rate: a pilot study | |
| EA200501496A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| DE69727922D1 (de) | Schnell zerfallende orale dosierungsform | |
| DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| CA2321700A1 (en) | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein | |
| BG101118A (en) | Therapeutical compounds | |
| BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
| CA2338005A1 (en) | Peptide antagonists of zonulin and methods for use of the same | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
| NZ516477A (en) | Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders | |
| RU2218917C2 (ru) | Применение специфического антагониста 5ht2 рецепторов для приготовления лекарств, пригодных для лечения синдрома апноэ во сне | |
| Bharucha et al. | Taking a lesson from microbial diarrheagenesis in the management of chronic constipation | |
| CA2120062A1 (en) | Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy | |
| SE9502219D0 (sv) | Novel medical use | |
| BRPI0412430A (pt) | polipeptìdeo agonista do receptor de zot e zonulina | |
| JP2002519391A5 (sv) | ||
| BR0107960A (pt) | Tratamento de condições alérgicas e inflamatórias | |
| CA2433785A1 (en) | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof | |
| DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
| Stancic-Rokotov et al. | Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| RU97120700A (ru) | Новое фармакологическое применение антагонистов a-ii рецептора |